CVS Heath (CVS) Q4 2023 earnings

The company lowered its 2024 adjusted earnings forecast to at least $8.30 per share, down from previous guidance of at least $8.50 per share. 

Related Keywords

,Cvs Health On ,Aetna ,Wall Street ,Signify Health ,Oak Street Health ,Business ,Biotechnology ,Biotech And Pharmaceuticals ,Pharmaceuticals ,Health Care Industry ,Earnings ,Breaking News ,Cvs Health Corp ,Humana Inc ,Business News ,